BIO
Michelle Verhaeghe
Vice President, Head of FSP Clinical Operations
With nearly 25 years of industry experience, Michelle brings extensive knowledge of clinical trial delivery, spanning project and program management, study start-up, monitoring, and managerial and leadership positions across clinical delivery.
Work experience
She has 17 years of experience within FSP delivery models, holding positions of increasing responsibility throughout her tenure with ExecuPharm prior to its acquisition by Parexel in 2017. Earlier career roles included work in clinical development for a large pharmaceutical organization. Michelle has led multiple large FSP programs, building and growing client partnerships from inception to execution at scale.
Education
Michelle holds a Master’s of Science degree in Biotechnology, Business Enterprise from John Hopkins University and a Bachelor’s degree from University of North Carolina.